Significance of Epidermal Growth Factor Receptor (EGFR) upregulation in the prediction of the malignant transformation risk in oral potentially malignant disorders: a systematic review and meta-analysis

  • 0School of Dentistry, University of Granada. Biohealth Research Institute, Ibs.Granada, Granada, Spain.

|

|

Summary

This summary is machine-generated.

Epidermal Growth Factor Receptor (EGFR) upregulation is a significant predictor of malignant transformation risk in oral potentially malignant disorders (OPMD). This finding highlights EGFR as a key biomarker for OPMD progression.

Area Of Science

  • Oncology
  • Oral Pathology
  • Biomarker Research

Background

  • Oral potentially malignant disorders (OPMD) carry a risk of malignant transformation.
  • Identifying reliable biomarkers for predicting this transformation is crucial for early intervention.

Purpose Of The Study

  • To systematically review and meta-analyze existing evidence on the role of EGFR upregulation in predicting OPMD malignant transformation risk.
  • To quantitatively and qualitatively appraise the association between EGFR and OPMD progression.

Main Methods

  • Comprehensive literature search across major databases (Web of Science, Embase, PubMed, Scopus).
  • Inclusion of longitudinal primary studies (prospective and retrospective).
  • Quality assessment using the QUIPS tool, followed by meta-analysis and sensitivity analyses.

Main Results

  • Eight studies (nine analytical units) involving 653 patients were included.
  • EGFR upregulation showed a significant association with increased OPMD malignant transformation risk (RR = 2.17).
  • Subgroup analyses confirmed associations for EGFR protein overexpression, gene amplification, and specific cutoff points (>10% nuclear staining).

Conclusions

  • EGFR overexpression, particularly via immunohistochemistry, serves as a valuable risk marker for OPMD malignant transformation.
  • This supports the potential clinical utility of EGFR assessment in managing OPMD patients.

Related Concept Videos

Mitogens and the Cell Cycle 02:38

6.3K

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

mTOR Signaling and Cancer Progression 03:03

3.7K

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation 02:23

4.4K

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Cancer-Critical Genes I: Proto-oncogenes 01:33

8.6K

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Barrett Esophagus-I: Introduction 01:21

45

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...

Tumor Progression 02:07

6.2K

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...